⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 1, 1995TransfusionOpen Access

Will human immunodeficiency virus p24 antigen screening increase the safety of the blood supply and, if so, at what cost?

Michael P. Busch Harvey J. Alter

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Will human immunodeficiency virus p24 antigen screening increase the safety

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Busch et al. (1995) studied this question.

synapsesocial.com/papers/6aa6a4023f249affa9f4cb97 https://doi.org/10.1046/j.1537-2995.1995.35795357872.x

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1How much would the safety of blood transfusion be improved by including p24 antigen in the battery of tests?Original Research · 1995 · 19 citations
2High Titers of Cytopathic Virus in Plasma of Patients with Symptomatic Primary HIV-1 InfectionOriginal Research · 1991 · 689 citations
3Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV AntibodyOriginal Research · 1988 · 467 citations
4Prevalence of Human Immunodeficiency Virus Type 1 p24 Antigen in U.S. Blood Donors — An Assessment of the Efficacy of Testing in Donor ScreeningOriginal Research · 1990 · 128 citations
5Screening of Selected Male Blood Donors for p24 Antigen of Human Immunodeficiency Virus Type 1Original Research · 1990 · 100 citations

More related papers

Infectious disease markers in blood donors in northern Thailand1995
Unsuspected Primary Human Immunodeficiency Virus Type 1 Infection in Seronegative Emergency Department Patients1994
Estimation of Current Human Immunodeficiency Virus Incidence Rates from a Cross-Sectional Survey Using Early Diagnostic Tests1995

More from Transfusion

Long‐term temporal trends in hepatitis B and C among blood donors in Brazil: Prevalence, incidence, and demographic correlates from the REDS multicenter programMon,
Effective combined immunotherapy for severe hemolytic disease of the fetusTue,